Perlara

Perlara YC Application

Winter 2016Active

Perlara went through Y Combinator in the Winter 2016 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Winter 2016
Industry
HealthcareDrug Discovery and Delivery
Team size
1
Status
Active
Launched
2016

What Perlara does

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

Perlara's YC application, reconstructed

Y Combinator application

Perlara, Winter 2016 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Perlara

Describe what your company does in 50 characters or less.

Building the YC for rare disease parents

What is your company going to make? Please describe your product and what it does or will do.

We build a predictive R&D engine called ArkBase that uses gene-edited patient avatars to find repurposed drugs for rare diseases. We partner directly with rare disease families and clinics to launch clinical trials and spin out companies based on our experimental data.

Where do you live now, and where would the company be based after YC?

We're based in Oakland, CA, but operate remotely; the company remains distributed with virtual clinical development focus.

Explain your decision regarding location.

We chose Oakland as a base for proximity to Bay Area biotech and healthcare resources but maintain a distributed setup to stay close to patients and rare disease families worldwide.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real Perlara YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Perlara's public data (launch notes, founder backgrounds, product description). It shows how a company like Perlara would present itself to YC, not the text they submitted.

What YC batch was Perlara in?

Perlara was part of the Y Combinator Winter 2016 batch.

What does Perlara do?

Perlara: building the YC for rare disease parents

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Perlara's application, and every other YC batch, is in YC Insights.

More YC startups like Perlara